Physicians' Academy for Cardiovascular Education

Estimating individual lifetime benefit and bleeding risk with NOAC addition to asprin in stable CVD

5' education - Oct. 14, 2019 - Paris, France - Tamar de Vries, MD – Utrecht, The Netherlands

Educational information

In the Cardiovascular Scene Investigation (CSI) series, investigators from Utrecht report at the ESC congress, from the perspective of young investigators. They put a question to researchers about presented study results.


Tamar de Vries, MD – PhD candidate, UMC Utrecht, The Netherlands


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.

Click here to go to U-prevent

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: